Skip Navigation and Go To Content

Office of Strategic Industry Initiatives

Industry Related Funding Opportunities:

Kite, A Gilead Company -- Cell Therapy External Research Program 
Kite develops innovative cancer immunotherapies, focus on chimeric antigen receptor and T-cell receptor engineered cell therapies. Research program focuses on novel combinations, side-effect/safety management, orphan malignancies, real world data, translational studies characterizing treatment failure, relapse, etc.
Deadline: Rolling

   Novel HIV Prevention Research Utilizing F/TAF Program
   LOI Deadline: August 23, 2019
   Liver Diseases: 
       HIV/HCV Co-infection NoCo, LOI deadline: August 9
       HBV CARE, LOI Deadline: September 15
       PSC PACE, LOI Submission: September 16-October 11

Merck Investigator Studies Program - 2019
   Diabetes and Metabolism (deadline: Oct 10)
   Bacterial Infections (deadline: Oct 18)
   CMV (deadline: Aug 9)
   HIV (deadline Sept 17)
   Oncology - Pembrolizumab, olaparib and Selumetinib (various)
   Cough (deadline, monthly in 2019)
   Anesthesia (deadline: Sep 2)
   Perioperative Care (deadline Sep 2)
   Vaccines -- many
   Women's Health - Contraception
   Women's Health - Fertility

Atomwise Artificial Intelligence Molecular Screen Awards Program
Deadline: October 28, 2019

Bayer Grants4Targets
Call coming August 1, 2019

Bayer Partnerships in Consumer Health
No deadline

Pfizer ASPIRE Grants

Adapting Patient Reported Outcome (PRO) Tools to Include Patient Preference Measures
LOI due date: August 5, 2019

Quality of Life / Patient Reported Outcomes Measures in ATTR Amyloidosis
Deadline: August 2, 2019

2019 Global Breast Cancer Competitive Research Grant Program
LOI due date: October 15, 2019

ADVANCE Global Awards for Advancing Chronic Pain Research
Deadline: August 8, 2019

Hemophilia ASPIRE 2019 (Global)
Full Proposal Deadline: August 31, 2019

Delta Dental Scientific Research Grant
Rolling reviews, generally quarterly

Sony Research Award Program
Deadline: September 15, 2019
--Advanced Image Processing enabled by AI
--Intelligent Sensing Technologies for Digital Health

NASH and Boehringer Ingelheim 
Technologies for Cardiovascular Diseases, Bayer
Glaucoma, Macular Degeneration and Boehringer Ingelheim
Ophthalmology and Thea Pharmacueticals
Heart Failure treatment and Servier
Innovative targets for endocrine diseases or kidney diseases, Taisho Pharmaceuticals
(Contact Melissa for further information)


Industry Related Funding Opportunities
(OSII can help find and/or cultivate industry partners!)


Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed)
Expiration Date: March 4, 2021

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required)
Expiration Date: August 26, 2021